GC2202 Study Site 506

Cluj-Napoca, RO 400015

1 studies enrolling now · 1 studies all time

What they study most

B-cell Chronic Lymphocytic Leukemia, Bacterial Infections, Hypogammaglobulinemia, Multiple Myleoma, Non-Hodgkin Lymphoma

Studies at this site

• A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma — Recruiting now